Home > Healthcare > Medical Devices > Diagnostic Devices > Newborn Screening Market

Newborn Screening Market Trends

  • Report ID: GMI8223
  • Published Date: Feb 2024
  • Report Format: PDF

Newborn Screening Market Trends

The rising incidence of genetic and metabolic disorders has significantly contributed to an escalating demand for newborn screening. This heightened demand stems from the pressing need to identify and address these disorders at the earliest stages of life. Growing awareness among healthcare professionals and the general public about the benefits of newborn screening has fuelled its demand. As understanding of the importance of early detection grows, more parents are likely to opt for screening for their newborns.
 

  • Governments and healthcare organizations worldwide are recognizing the importance of newborn screening in public health initiatives. Efforts are being made to expand screening programs to cover a broader range of disorders, reflecting a commitment to addressing the increasing prevalence of genetic and metabolic conditions.
     
  • Early detection of genetic and metabolic disorders provides families with valuable information for family planning and decision-making. It allows for informed choices and facilitates genetic counseling to help families understand the implications of such conditions.
     
  • Moreover, technological advancements, such as the incorporation of advanced genetic testing methods, have enhanced the accuracy and scope of newborn screening. These innovations contribute to the identification of a wider array of genetic and metabolic disorders.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global newborn screening market was valued at around USD 950.5 Million in 2023 and is estimated to reach over USD 1.8 Billion by 2032 owing to the strategic shift towards a more inclusive and detailed assessment of a newborn's health.

The instruments segment is poised for significant development at 7.8% CAGR from 2024 to 2032 fueled by ongoing technological advancements that are enhancing the capabilities of newborn screening instruments.

North America newborn screening market accounted for USD 431.3 million in 2023 and is predicted to witness substantial growth from 2024 to 2032, attributed to the integration of newborn screening data with electronic health records, along with the adoption of advanced genetic testing technologies for precision & scope of screening efforts.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, PerkinElmer, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Waters Corporation.

Newborn Screening Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 134
  • Countries covered: 22
  • Pages: 150
 Download Free Sample